Sign in
4

Changes in Ownership

BIOGEN INC. Filed Acc 0001127602-20-005770

EVP, Research & Development gave up 1,901 shares (to pay taxes)

  • EVP, Research & Development acquired 5,216 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Sandrock Alfred · EVP, Research & Development

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2020-02-12 Exercise or conversion : show line 1 in the form +2,211 12,702.25 D
2020-02-12 Shares withheld for taxes : show line 2 in the form −660 $331.76 $218,962 12,042.25 D
2020-02-12 Exercise or conversion : show line 3 in the form +1,422 13,464.25 D
2020-02-12 Shares withheld for taxes : show line 4 in the form −538 $331.76 $178,487 12,926.25 D
2020-02-12 Exercise or conversion : show line 5 in the form +1,583 14,509.25 D
2020-02-12 Shares withheld for taxes : show line 6 in the form −703 $331.76 $233,227 13,806.25 D

Table II: Derivative

6 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2020-02-12 Exercise or conversion : show line 7 in the form Restricted Stock Unit −2,211 $0.00 2020-02-12 2,211 0 D
2020-02-12 Exercise or conversion : show line 8 in the form Restricted Stock Unit −1,422 $0.00 2021-02-12 1,422 4,106 D
2020-02-12 Other disposition : show line 9 in the form Restricted Stock Unit −1,340 $0.00 2021-02-12 1,340 2,766 D
2020-02-12 Exercise or conversion : show line 10 in the form Restricted Stock Unit −1,583 $0.00 2022-02-12 1,583 8,747 D
2020-02-12 Other disposition : show line 11 in the form Restricted Stock Unit −1,859 $0.00 2022-02-12 1,859 6,888 D
2020-02-12 Grant or award : show line 12 in the form Restricted Stock Unit +12,060 $0.00 2023-02-12 12,060 12,060 D
Loading xslF345X03/form4.xml…